What are the side effects and risks of an overdose of Luvox (fluvoxamine)?

Side Effects of Excessive Luvox (Fluvoxamine)

Excessive Luvox can cause serious and potentially life-threatening complications including gastrointestinal distress, cardiac abnormalities, seizures, and in severe cases, death—though fatalities are rare and typically occur with very high doses or when combined with other substances.

Common Overdose Symptoms

The most frequently observed side effects of fluvoxamine overdose include 1:

• Gastrointestinal effects (≥5% of cases): Nausea, vomiting, and diarrhea
• Central nervous system effects: Somnolence, coma, dizziness, tremor, and increased reflexes
• Cardiovascular effects: Tachycardia, hypotension, bradycardia
• Metabolic disturbances: Hypokalemia
• Respiratory complications: Respiratory difficulties

Serious and Life-Threatening Complications

Cardiac Effects

ECG abnormalities are a significant concern with fluvoxamine overdose 1. These include:

• QT interval prolongation
• Heart arrest
• First-degree atrioventricular block
• Bundle branch block
• Junctional rhythm
• Both bradycardia and tachycardia (dose-dependent)

Neurological Complications

• Seizures/convulsions: More common with doses exceeding 1,500 mg 2
• Prolonged cerebral depression
• Hypoxic encephalopathy (in severe cases) 1
• Increased reflexes and myoclonus

Other Severe Sequelae

Documented long-term complications from overdose include 1:

• Persistent mydriasis
• Unsteady gait
• Kidney complications
• Bowel infarction (requiring surgical intervention)
• Vegetative state (rare)

Dose-Related Toxicity Profile

The severity of symptoms correlates with ingested dose 2:

• Below 1,000 mg: Symptoms are typically benign—drowsiness, tremor, nausea, mild bradycardia, anticholinergic effects (dry mouth, mydriasis, urinary retention)
• 1,000-1,500 mg: Moderate symptoms with increased risk of complications
• Above 1,500 mg: High risk of seizures and severe toxicity
• Reported range: Overdoses up to 9,000-12,000 mg have resulted in full recovery 3, 1, though ingestions as low as 1,400 mg have been associated with death 1

Critical Context: Polypharmacy Risk

The majority (77%) of fluvoxamine overdose cases involve co-ingestion of other substances 2, particularly:

• Benzodiazepines
• Other antidepressants (especially tricyclics)
• Neuroleptics
• Alcohol

This is clinically crucial because fluvoxamine inhibits multiple cytochrome P450 enzymes (CYP1A2, CYP2C19, CYP2C9, CYP3A4, CYP2D6) 4, which can dramatically increase levels of co-ingested medications, particularly tricyclic antidepressants, potentially extending toxicity and complicating management 1.

Serotonin Syndrome Risk

When excessive fluvoxamine is combined with other serotonergic agents, life-threatening serotonin syndrome can develop 4. This manifests as:

• Mental status changes: Confusion, agitation, anxiety
• Neuromuscular hyperactivity: Tremors, clonus, hyperreflexia, muscle rigidity
• Autonomic hyperactivity: Hypertension, tachycardia, arrhythmias, tachypnea, diaphoresis, shivering, vomiting, diarrhea
• Advanced symptoms: Fever, seizures, arrhythmias, unconsciousness, potentially fatal 4

Mortality Data

Death from fluvoxamine overdose alone is rare 3, 5. From worldwide experience:

• Of 539 reported overdose cases, 55 deaths occurred
• Only 9 deaths involved fluvoxamine alone
• 46 deaths involved polypharmacy 1
• One documented fatality had a postmortem blood concentration of 4.9 mg/L 6

Therapeutic Dose Side Effects vs. Overdose

It's important to distinguish overdose from adverse effects at therapeutic doses. At therapeutic doses, fluvoxamine commonly causes 1:

• Nausea (most common reason for discontinuation—9%)
• Insomnia (4%)
• Somnolence (4%)
• Sexual dysfunction (abnormal ejaculation, decreased libido, anorgasmia)
• Discontinuation syndrome (dizziness, fatigue, nausea, sensory disturbances) 4

Special Populations at Higher Risk

Patients with pre-existing conditions face amplified risks 7:

• History of seizures or head trauma: Increased seizure susceptibility
• Cardiac conduction abnormalities: Greater risk of arrhythmias
• Long QT syndrome: Contraindicated due to QT prolongation risk 4

Management Principles

No specific antidote exists for fluvoxamine overdose 1. Treatment is supportive:

• Ensure adequate airway, oxygenation, ventilation
• Cardiac monitoring for rhythm abnormalities
• Activated charcoal if presented early
• Gastric lavage may be indicated if performed soon after ingestion
• Forced diuresis, dialysis, and hemoperfusion are ineffective due to large volume of distribution 1
• Contact poison control center (1-800-222-1222 in US) for guidance 1

Key Clinical Pitfall

The most dangerous scenario is when fluvoxamine overdose occurs in patients recently taking or currently taking tricyclic antidepressants 1. Fluvoxamine's potent enzyme inhibition causes accumulation of tricyclics and their active metabolites, dramatically increasing cardiotoxicity risk and extending the observation period required.